XPEDITE SYSTEMS INC
SC 13D, 1997-07-07
TELEGRAPH & OTHER MESSAGE COMMUNICATIONS
Previous: XPEDITE SYSTEMS INC, SC 13D/A, 1997-07-07
Next: INTERNEURON PHARMACEUTICALS INC, 8-K, 1997-07-07




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D

                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                                (Amendment No.____)*

                              Xpedite Systems, Inc.
                              ---------------------
                                (Name of Issuer)

                     COMMON STOCK, PAR VALUE $.01 PER SHARE
                     --------------------------------------
                         (Title of Class of Securities)

                                    893929100
                                    ---------
                                 (CUSIP Number)

                            Martha J. Flanders, Esq.
                    Lowenthal, Landau, Fischer & Bring, P.C.
                                 250 Park Avenue
                            New York, New York 10177
                             Tel. No. (212) 986-1116
                             -----------------------
            (Name, Address and Telephone Number of Person Authorized
                     to Receive Notices and Communications)

                                  June 26, 1997
                                  -------------
             (Date of Event Which Requires Filing of this Statement)


If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].


     Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.


- --------

The  remainder  of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to the "filed" for the purpose of Section 18 of the  Securities  Exchange Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).



<PAGE>

                                  SCHEDULE 13D

CUSIP No. 893929100


1    NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     Robert A. Epstein

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a)[ ] (b)[ ]

3    SEC USE ONLY


4    SOURCE OF FUNDS*

     PF

5    CHECK BOX IF DISCLOSURE OF LEGAL  PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
     2(d) OR 2(e)  [ ]

6    CITIZENSHIP OR PLACE OF ORGANIZATION

     USA

7.   NUMBER OF SHARES  BENEFICIALLY  OWNED BY EACH  REPORTING  PERSON  WITH SOLE
     VOTING POWER

     529,734

8.   NUMBER OF SHARES  BENEFICIALLY  OWNED BY EACH REPORTING  PERSON WITH SHARED
     VOTING POWER

     None

9.   NUMBER OF SHARES  BENEFICIALLY  OWNED BY EACH  REPORTING  PERSON  WITH SOLE
     DISPOSITIVE POWER

     529,734

10.  NUMBER OF SHARES  BENEFICIALLY  OWNED BY EACH REPORTING  PERSON WITH SHARED
     DISPOSITIVE POWER

     None

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     529,734

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ]


13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     5.65%

14   TYPE OF REPORTING PERSON*

     IN


                      *SEE INSTRUCTIONS BEFORE FILLING OUT!



                               Page 2 of 6 pages

<PAGE>

                                  SCHEDULE 13D

CUSIP No. 893929100


Item 1.           Security and Issuer.

                  This  statement on Schedule  13D relates to the common  stock,
par value $.01 per share (the Common  Stock"),  of  Expedite  Systems,  Inc.,  a
Delaware  corporation  ("Xpedite" or the  "Company").  The  principal  executive
office of Xpedite is located at 446 Highway 35, Eatontown, New Jersey 07724.

Item 2.           Identity and Background.

                  This  statement  on  Schedule  13D is being filed by Robert A.
Epstein (the "Reporting  Person") whose business address is 88 Field Point Road,
Greenwich,  CT 06836-2408.  The Reporting  Person is a real estate developer and
part-time practicing attorney.  During the last five years, the Reporting Person
has not been convicted in any criminal proceeding  (excluding traffic violations
or similar  misdemeanors)  nor during that time has the Reporting  Person been a
party to a civil  proceeding of a judicial or  administrative  body of competent
jurisdiction  which resulted in a judgment,  decree or final order enjoining the
Reporting  Person  from  future  violations  of,  or  prohibiting  or  mandating
activities  subject to, federal or state  securities  laws or any finding of any
violation  with respect to such laws.  The Reporting  Person is a citizen of the
United States.

Item 3.           Source and Amount of Funds or Other Consideration.

                  During the period  from June 26,  1997 to the date  hereof the
Reporting  Person purchased an aggregate of 69,800 shares of Common Stock for an
aggregate  purchase price of $1,240,450  which amount was paid with the proceeds
of loans from the Reporting Person's margin brokerage accounts with Smith Barney
and Punk  Ziegel.  Each  margin  account is  governed  by the  brokerage  firm's
standard agreement.

Item 4.           Purpose of Transaction.

                  The Reporting  Person acquired the Common Stock for investment
purposes  only. The Reporting  Person has no plans or proposals  relating to the
matters  described  in  subclauses  (a)  through  (j) of  Item 4 of the  General
Instructions to Schedule 13D.

Item 5.           Interest in Securities of the Issuer.

                  (a) As of the date hereof,  the Reporting  Person owns 529,734
shares of the Company's Common Stock which represents approximately 5.65% of the
Company's outstanding common stock.

                  (b) The Reporting  Person has sole voting and investment power
with respect to the 529,734 shares of Common Stock referred to herein.

                  (c) No  transactions  in the Common Stock were effected during
the past sixty days by the Reporting Person except:

                  On June 3, 1997,  the  Reporting  Person  made an open  market
purchase  of 2,500  shares of Common  Stock at a price of $18.50 per share which
transaction  was  effected  in the over the counter  market by or through  Smith
Barney.


                               Page 3 of 6 pages

<PAGE>

                                  SCHEDULE 13D

CUSIP No. 893929100


                  On June 10,  1997,  the  Reporting  Person made an open market
purchase of 10,000  shares of Common Stock at a price of $18.625 per share which
transaction  was  effected  in the over the counter  market by or through  Smith
Barney.

    On June 11, 1997, the Reporting Person made an open market purchase of 6,000
shares of Common  Stock at a price of $18.375  per share which  transaction  was
effected in the over the counter market by or through Smith Barney.

    On June 11,  1997,  the  Reporting  Person made an open  market  purchase of
56,000 shares of Common Stock at a price of $18.375 per share which  transaction
was effected in the over the counter market by or through Punk Ziegel.

    On June 24, 1997, the Reporting Person made an open market purchase of 2,200
shares of Common  Stock at a price of $18.250  per share which  transaction  was
effected in the over the counter market by or through Smith Barney.

    On June 26,  1997,  the  Reporting  Person made an open  market  purchase of
15,000 shares of Common Stock at a price of $17.125 per share which  transaction
was effected in the over the counter market by or through Punk Ziegel.

    On June 26,  1997,  the  Reporting  Person made an open  market  purchase of
12,500 shares of Common Stock at a price of $17.090 per share which  transaction
was effected in the over the counter market by or through Smith Barney.

    On June 27,  1997,  the  Reporting  Person made an open  market  purchase of
12,500 shares of Common Stock at a price of $17.125 per share which  transaction
was effected in the over the counter market by or through Punk Ziegel.

    On June 27, 1997, the Reporting Person made an open market purchase of 1,800
shares of Common  Stock at a price of $17.125  per share which  transaction  was
effected in the over the counter market by or through Smith Barney.

    On June 30, 1997, the Reporting Person made an open market purchase of 7,500
shares of Common  Stock at a price of $17.375  per share which  transaction  was
effected in the over the counter market by or through Punk Ziegel.

    On July 1, 1997, the Reporting Person made an open market purchase of 20,500
shares of Common  Stock at a price of $17.500  per share which  transaction  was
effected in the over the counter market by or through Smith Barney.

    (d)  Not applicable.

    (e)  Not applicable.


                               Page 4 of 6 pages

<PAGE>

                                  SCHEDULE 13D

CUSIP No. 893929100


Item 6.           Contracts, Arrangements, Understandings or Relationships 
                  With Respect to Securities of the Issuer.

                  Not applicable.

Item 7.           Material to be Filed as Exhibits.

                  None.


                               Page 5 of 6 pages

<PAGE>

                                  SCHEDULE 13D

CUSIP No. 893929100


                                    SIGNATURE

    After  reasonable  inquiry and to the best of our knowledge and belief,  the
undersigned  certify that the  information  set forth in this statement is true,
complete and correct.


Dated:  July 7, 1997



                                             /s/ Robert A. Epstein
                                             -----------------------
                                             Robert A. Epstein






                               Page 6 of 6 pages



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission